Electrophysiologic remodeling of the left ventricle in pressure overload-induced right ventricular failure. 2012

Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
Heart Failure Research Center, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.

OBJECTIVE The purpose of this study was to analyze the electrophysiologic remodeling of the atrophic left ventricle (LV) in right ventricular (RV) failure (RVF) after RV pressure overload. BACKGROUND The LV in pressure-induced RVF develops dysfunction, reduction in mass, and altered gene expression, due to atrophic remodeling. LV atrophy is associated with electrophysiologic remodeling. METHODS We conducted epicardial mapping in Langendorff-perfused hearts, patch-clamp studies, gene expression studies, and protein level studies of the LV in rats with pressure-induced RVF (monocrotaline [MCT] injection, n = 25; controls with saline injection, n = 18). We also performed epicardial mapping of the LV in patients with RVF after chronic thromboembolic pulmonary hypertension (CTEPH) (RVF, n = 10; no RVF, n = 16). RESULTS The LV of rats with MCT-induced RVF exhibited electrophysiologic remodeling: longer action potentials (APs) at 90% repolarization and effective refractory periods (ERPs) (60 ± 1 ms vs. 44 ± 1 ms; p < 0.001), and slower longitudinal conduction velocity (62 ± 2 cm/s vs. 70 ± 1 cm/s; p = 0.003). AP/ERP prolongation agreed with reduced Kcnip2 expression, which encodes the repolarizing potassium channel subunit KChIP2 (0.07 ± 0.01 vs. 0.11 ± 0.02; p < 0.05). Conduction slowing was not explained by impaired impulse formation, as AP maximum upstroke velocity, whole-cell sodium current magnitude/properties, and mRNA levels of Scn5a were unaltered. Instead, impulse transmission in RVF was hampered by reduction in cell length (111.6 ± 0.7 μm vs. 122.0 ± 0.4 μm; p = 0.02) and width (21.9 ± 0.2 μm vs. 25.3 ± 0.3 μm; p = 0.002), and impaired cell-to-cell impulse transmission (24% reduction in Connexin-43 levels). The LV of patients with CTEPH with RVF also exhibited ERP prolongation (306 ± 8 ms vs. 268 ± 5 ms; p = 0.001) and conduction slowing (53 ± 3 cm/s vs. 64 ± 3 cm/s; p = 0.005). CONCLUSIONS Pressure-induced RVF is associated with electrophysiologic remodeling of the atrophic LV.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D015222 Sodium Channels Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function. Ion Channels, Sodium,Ion Channel, Sodium,Sodium Channel,Sodium Ion Channels,Channel, Sodium,Channel, Sodium Ion,Channels, Sodium,Channels, Sodium Ion,Sodium Ion Channel
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017725 Ventricular Pressure The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., DOPPLER ECHOCARDIOGRAPHY). The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures. Intraventricular Pressure,Intraventricular Pressures,Pressure, Intraventricular,Pressure, Ventricular,Pressures, Intraventricular,Pressures, Ventricular,Ventricular Pressures

Related Publications

Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
February 2011, Journal of the American College of Cardiology,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
September 1983, Journal of the American College of Cardiology,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
April 2016, Journal of cardiovascular pharmacology,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
September 2013, International journal of cardiology,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
August 2021, Scientific reports,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
April 2016, Acta pharmacologica Sinica,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
July 2016, American journal of physiology. Heart and circulatory physiology,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
January 2013, PloS one,
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
June 2014, Hypertension (Dallas, Tex. : 1979),
Maxim Hardziyenka, and Maria E Campian, and Arie O Verkerk, and Sulaiman Surie, and Antoni C G van Ginneken, and Sara Hakim, and André C Linnenbank, and H A C M Rianne de Bruin-Bon, and Leander Beekman, and Mart N van der Plas, and Carol A Remme, and Toon A B van Veen, and Paul Bresser, and Jacques M T de Bakker, and Hanno L Tan
November 1997, Journal of the American College of Cardiology,
Copied contents to your clipboard!